| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.831 | 0.004 | 0.872 | Caspase 3 stimulant | 0.872 0.003 CID_105131 | CID_105131 | |
| 0.761 | 0.002 | 0.761 | Histone deacetylase SIRT2 inhibitor | 0.428 0.003 CID_105131 | ||
| 0.728 | 0.003 | 0.728 | Histone deacetylase class III inhibitor | 0.439 0.004 CID_105131 | ||
| 0.647 | 0.002 | 0.647 | Human rhinovirus A protease inhibitor | 0.582 0.002 CID_105131 | ||
| 0.557 | 0.005 | 0.557 | Glycogen synthase kinase-3 inhibitor | 0.304 0.015 CID_105131 | ||
| 0.563 | 0.012 | 0.563 | GABA C receptor rho-3 antagonist | 0.509 0.024 CID_105131 | ||
| 0.552 | 0.005 | 0.552 | Glycogen synthase kinase-3 beta inhibitor | 0.321 0.012 CID_105131 | ||
| 0.549 | 0.004 | 0.737 | Alpha-N-acetylglucosaminidase inhibitor | 0.737 0.003 CID_105131 | CID_105131 | |
| 0.516 | 0.027 | 0.516 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.512 0.029 CID_105131 | ||
| 0.464 | 0.003 | 0.464 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.41 0.004 CID_105131 | ||
| 0.455 | 0.004 | 0.514 | UDP-glucose 4-epimerase inhibitor | 0.514 0.002 CID_105131 | CID_105131 | |
| 0.441 | 0.003 | 0.441 | Ferrochelatase inhibitor | 0.396 0.004 CID_105131 | ||
| 0.436 | 0.004 | 0.436 | GABA C receptor agonist | 0.365 0.006 CID_105131 | ||
| 0.459 | 0.034 | 0.459 | 5 Hydroxytryptamine release stimulant | 0.297 0.071 CID_105131 | ||
| 0.462 | 0.038 | 0.462 | Aldehyde oxidase inhibitor | 0.423 0.044 CID_105131 | ||
| 0.414 | 0.019 | 0.414 | Peroxidase inhibitor | 0.32 0.034 CID_105131 | ||
| 0.393 | 0.008 | 0.393 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.356 0.012 CID_105131 | ||
| 0.401 | 0.021 | 0.48 | DNA synthesis inhibitor | 0.48 0.015 CID_105131 | CID_105131 | |
| 0.42 | 0.066 | 0.42 | 5 Hydroxytryptamine release inhibitor | 0.358 0.109 CID_105131 | ||
| 0.373 | 0.02 | 0.373 | 5 Hydroxytryptamine uptake stimulant | 0.311 0.039 CID_105131 | ||
| 0.347 | 0.008 | 0.616 | Aldehyde dehydrogenase inhibitor | 0.616 0.004 CID_105131 | CID_105131 | |
| 0.371 | 0.035 | 0.371 | DNA damaging | 0.312 0.052 CID_105131 | ||
| 0.346 | 0.017 | 0.346 | Tyrosine 3 hydroxylase inhibitor | 0.305 0.031 CID_105131 | ||
| 0.417 | 0.101 | 0.417 | Caspase 9 stimulant | 0.381 0.123 CID_105131 | ||
| 0.31 | 0.003 | 0.559 | Glutamate decarboxylase inhibitor | 0.559 0.002 CID_105131 | CID_105131 | |
| 0.304 | 0.003 | 0.304 | Melatonin 1 antagonist | 0.074 0.004 CID_105131 | ||
| 0.348 | 0.051 | 0.348 | Calcium channel activator | 0.309 0.083 CID_105131 | ||
| 0.299 | 0.003 | 0.326 | Thioredoxin reductase inhibitor | 0.326 0.003 CID_105131 | CID_105131 | |
| 0.289 | 0.003 | 0.289 | Fumarate hydratase inhibitor | 0.201 0.003 CID_105131 | ||
| 0.274 | 0.003 | 0.274 | Melatonin antagonist | 0.09 0.005 CID_105131 | ||
| 0.279 | 0.013 | 0.352 | Hexokinase inhibitor | 0.352 0.006 CID_105131 | CID_105131 | |
| 0.294 | 0.028 | 0.294 | DNA methyltransferase I inhibitor | 0.279 0.035 CID_105131 | ||
| 0.279 | 0.018 | 0.279 | Nitric-oxide synthase stimulant | 0.25 0.032 CID_105131 | ||
| 0.274 | 0.016 | 0.367 | Succinate dehydrogenase inhibitor | 0.367 0.005 CID_105131 | CID_105131 | |
| 0.255 | 0.007 | 0.255 | Porphobilinogen synthase inhibitor | 0.251 0.008 CID_105131 | ||
| 0.281 | 0.034 | 0.281 | DNA methylase inhibitor | 0.261 0.042 CID_105131 | ||
| 0.295 | 0.049 | 0.364 | Pyruvate kinase inhibitor | 0.364 0.029 CID_105131 | CID_105131 | |
| 0.256 | 0.014 | 0.256 | 5 Hydroxytryptamine 3E antagonist | 0.243 0.019 CID_105131 | ||
| 0.277 | 0.037 | 0.277 | RNA-directed DNA polymerase inhibitor | 0.259 0.044 CID_105131 | ||
| 0.246 | 0.01 | 0.33 | Adenylate kinase inhibitor | 0.33 0.005 CID_105131 | CID_105131 | |
| 0.29 | 0.054 | 0.45 | Superoxide dismutase inhibitor | 0.45 0.019 CID_105131 | CID_105131 | |
| 0.245 | 0.01 | 0.245 | Breast cancer-resistant protein inhibitor | 0.131 0.032 CID_105131 | ||
| 0.244 | 0.009 | 0.244 | Histidine decarboxylase inhibitor | 0.226 0.01 CID_105131 | ||
| 0.229 | 0.007 | 0.432 | TRPA1 agonist | 0.432 0.004 CID_105131 | CID_105131 | |
| 0.228 | 0.008 | 0.364 | Triose-phosphate isomerase inhibitor | 0.364 0.004 CID_105131 | CID_105131 | |
| 0.234 | 0.019 | 0.302 | Alkylator | 0.302 0.012 CID_105131 | CID_105131 | |
| 0.238 | 0.023 | 0.257 | Anesthetic local | 0.257 0.019 CID_105131 | CID_105131 | |
| 0.23 | 0.016 | 0.23 | GABA C receptor rho-2 antagonist | 0.197 0.03 CID_105131 | ||
| 0.216 | 0.011 | 0.343 | Alcohol dehydrogenase inhibitor | 0.343 0.004 CID_105131 | CID_105131 | |
| 0.21 | 0.006 | 0.633 | Alcohol oxidase inhibitor | 0.633 0.003 CID_105131 | CID_105131 | |
| 0.213 | 0.01 | 0.213 | GABA C receptor antagonist | 0.166 0.023 CID_105131 | ||
| 0.204 | 0.01 | 0.204 | NADH dehydrogenase inhibitor | 0.165 0.014 CID_105131 | ||
| 0.201 | 0.011 | 0.201 | Aminoacyl-tRNA synthetase inhibitor | 0.087 0.063 CID_105131 | ||
| 0.207 | 0.018 | 0.23 | Microtubule formation inhibitor | 0.23 0.014 CID_105131 | CID_105131 | |
| 0.199 | 0.011 | 0.273 | Phosphofructokinase-1 inhibitor | 0.273 0.006 CID_105131 | CID_105131 | |
| 0.207 | 0.026 | 0.207 | Arachidonic acid antagonist | 0.198 0.035 CID_105131 | ||
| 0.229 | 0.048 | 0.229 | Insulin sensitizer | 0.21 0.064 CID_105131 | ||
| 0.28 | 0.104 | 0.28 | Cholesterol antagonist | 0.245 0.129 CID_105131 | ||
| 0.181 | 0.006 | 0.181 | Ca2+-transporting ATPase inhibitor | 0.171 0.012 CID_105131 | ||
| 0.299 | 0.124 | 0.299 | Histamine release inhibitor | 0.232 0.169 CID_105131 | ||
| 0.185 | 0.011 | 0.185 | GABA C receptor rho-1 antagonist | 0.149 0.022 CID_105131 | ||
| 0.178 | 0.004 | 0.178 | Melatonin agonist | 0.055 0.008 CID_105131 | ||
| 0.189 | 0.019 | 0.189 | 5 Hydroxytryptamine 3A agonist | 0.145 0.038 CID_105131 | ||
| 0.208 | 0.039 | 0.208 | Lipid peroxidase inhibitor | |||
| 0.199 | 0.031 | 0.264 | Mannose-6-phosphate isomerase inhibitor | 0.264 0.009 CID_105131 | CID_105131 | |
| 0.195 | 0.028 | 0.195 | Topoisomerase I inhibitor | |||
| 0.182 | 0.014 | 0.182 | Creatine kinase inhibitor | 0.146 0.025 CID_105131 | ||
| 0.255 | 0.092 | 0.255 | Insulysin inhibitor | 0.236 0.11 CID_105131 | ||
| 0.164 | 0.002 | 0.164 | Glucose-6-phosphate dehydrogenase inhibitor | 0.088 0.003 CID_105131 | ||
| 0.252 | 0.09 | 0.252 | Spasmolytic | 0.23 0.1 CID_105131 | ||
| 0.224 | 0.062 | 0.224 | Anesthetic general | 0.182 0.085 CID_105131 | ||
| 0.171 | 0.009 | 0.171 | Carbamoyl phosphate synthetase inhibitor | 0.144 0.012 CID_105131 | ||
| 0.164 | 0.004 | 0.164 | Melatonin 2 agonist | 0.078 0.005 CID_105131 | ||
| 0.242 | 0.084 | 0.242 | 5 Hydroxytryptamine 1E antagonist | 0.21 0.12 CID_105131 | ||
| 0.169 | 0.014 | 0.169 | NAD(P)H dehydrogenase (quinone) inhibitor | 0.163 0.015 CID_105131 | ||
| 0.158 | 0.005 | 0.375 | CDC25B inhibitor | 0.375 0.003 CID_105131 | CID_105131 | |
| 0.159 | 0.008 | 0.159 | Acyl-CoA dehydrogenase inhibitor | 0.127 0.012 CID_105131 | ||
| 0.16 | 0.008 | 0.16 | Biliverdin reductase inhibitor | 0.129 0.012 CID_105131 | ||
| 0.164 | 0.015 | 0.164 | DOPA decarboxylase inhibitor | 0.158 0.017 CID_105131 | ||
| 0.178 | 0.03 | 0.178 | Cystathionine beta-synthase inhibitor | 0.141 0.045 CID_105131 | ||
| 0.224 | 0.077 | 0.224 | Cyclic AMP phosphodiesterase inhibitor | 0.168 0.125 CID_105131 | ||
| 0.176 | 0.029 | 0.176 | Adenylate cyclase stimulant | 0.157 0.052 CID_105131 | ||
| 0.157 | 0.014 | 0.157 | CYP2A6 inhibitor | 0.149 0.016 CID_105131 | ||
| 0.162 | 0.019 | 0.162 | Androgen antagonist | 0.152 0.022 CID_105131 | ||
| 0.159 | 0.019 | 0.159 | Urease inhibitor | 0.15 0.023 CID_105131 | ||
| 0.194 | 0.055 | 0.279 | 3C-like protease (Human coronavirus) inhibitor | 0.279 0.017 CID_105131 | CID_105131 | |
| 0.154 | 0.018 | 0.154 | Electrolyte absorption antagonist | 0.14 0.024 CID_105131 | ||
| 0.186 | 0.051 | 0.223 | Phospholipase A2 inhibitor | 0.223 0.032 CID_105131 | CID_105131 | |
| 0.229 | 0.095 | 0.229 | Interleukin agonist | 0.171 0.147 CID_105131 | ||
| 0.174 | 0.04 | 0.174 | MAP kinase 3 inhibitor | 0.148 0.07 CID_105131 | ||
| 0.149 | 0.016 | 0.149 | Glutamate dehydrogenase inhibitor | 0.139 0.018 CID_105131 | ||
| 0.222 | 0.093 | 0.294 | Calpain inhibitor | 0.294 0.033 CID_105131 | CID_105131 | |
| 0.139 | 0.011 | 0.255 | TRPA1 antagonist | 0.255 0.004 CID_105131 | CID_105131 | |
| 0.179 | 0.052 | 0.276 | Amylase inhibitor | 0.276 0.022 CID_105131 | CID_105131 | |
| 0.161 | 0.036 | 0.161 | Protein kinase (CK2) alpha inhibitor | 0.126 0.058 CID_105131 | ||
| 0.229 | 0.107 | 0.229 | Gastrin inhibitor | 0.182 0.176 CID_105131 | ||
| 0.16 | 0.039 | 0.206 | Cathepsin H inhibitor | 0.206 0.021 CID_105131 | CID_105131 | |
| 0.155 | 0.036 | 0.183 | Aminopeptidase B inhibitor | 0.183 0.026 CID_105131 | CID_105131 | |
| 0.127 | 0.01 | 0.193 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.193 0.007 CID_105131 | CID_105131 | |
| 0.147 | 0.03 | 0.2 | Caspase 3 inhibitor | 0.2 0.009 CID_105131 | CID_105131 | |
| 0.196 | 0.081 | 0.196 | Neurotrophic factor enhancer | 0.169 0.112 CID_105131 | ||
| 0.127 | 0.013 | 0.157 | Caspase 7 inhibitor | 0.157 0.006 CID_105131 | CID_105131 | |
| 0.139 | 0.027 | 0.149 | Prolactin inhibitor | 0.149 0.023 CID_105131 | CID_105131 | |
| 0.155 | 0.042 | 0.155 | Antibacterial (Helicobacter pylori) | 0.135 0.061 CID_105131 | ||
| 0.127 | 0.014 | 0.22 | Argininosuccinate synthase inhibitor | 0.22 0.007 CID_105131 | CID_105131 | |
| 0.118 | 0.006 | 0.118 | Aconitate hydratase inhibitor | 0.099 0.009 CID_105131 | ||
| 0.146 | 0.035 | 0.146 | Protein kinase (CK2) inhibitor | 0.108 0.057 CID_105131 | ||
| 0.122 | 0.015 | 0.122 | Granulocyte macrophage colony stimulating factor agonist | 0.12 0.016 CID_105131 | ||
| 0.167 | 0.06 | 0.167 | Interferon gamma antagonist | 0.154 0.073 CID_105131 | ||
| 0.137 | 0.031 | 0.137 | HIV-1 integrase (Overall Integration) inhibitor | 0.098 0.056 CID_105131 | ||
| 0.156 | 0.052 | 0.156 | Sphingosine 1-phosphate receptor 5 antagonist | 0.129 0.103 CID_105131 | ||
| 0.133 | 0.029 | 0.133 | Anabolic | 0.126 0.034 CID_105131 | ||
| 0.106 | 0.004 | 0.106 | Dopamine beta hydroxylase inhibitor | 0.09 0.004 CID_105131 | ||
| 0.12 | 0.018 | 0.12 | Phenylalanine 4-hydroxylase inhibitor | 0.089 0.031 CID_105131 | ||
| 0.149 | 0.048 | 0.149 | Heat shock protein 70 antagonist | 0.14 0.076 CID_105131 | ||
| 0.16 | 0.06 | 0.16 | CF transmembrane conductance regulator agonist | 0.149 0.077 CID_105131 | ||
| 0.117 | 0.017 | 0.201 | Amidase inhibitor | 0.201 0.006 CID_105131 | CID_105131 | |
| 0.17 | 0.072 | 0.17 | Phospholipase C inhibitor | 0.159 0.089 CID_105131 | ||
| 0.11 | 0.012 | 0.11 | Androgen agonist | 0.095 0.017 CID_105131 | ||
| 0.105 | 0.007 | 0.109 | Exportin-1 inhibitor | 0.109 0.006 CID_105131 | CID_105131 | |
| 0.11 | 0.012 | 0.158 | Protease 3C (Human rhinovirus) inhibitor | 0.158 0.006 CID_105131 | CID_105131 | |
| 0.118 | 0.02 | 0.118 | Aminopeptidase I inhibitor | 0.101 0.027 CID_105131 | ||
| 0.105 | 0.008 | 0.105 | Glutamate (mGluR7) antagonist | 0.098 0.012 CID_105131 | ||
| 0.105 | 0.009 | 0.105 | Glutamate (mGluR6) antagonist | 0.093 0.014 CID_105131 | ||
| 0.1 | 0.005 | 0.136 | Glucose-6-phosphate isomerase inhibitor | 0.136 0.003 CID_105131 | CID_105131 | |
| 0.144 | 0.05 | 0.144 | Sphingosine 1-phosphate receptor 2 antagonist | 0.119 0.1 CID_105131 | ||
| 0.115 | 0.021 | 0.115 | Glycine receptor antagonist | 0.099 0.033 CID_105131 | ||
| 0.135 | 0.042 | 0.135 | Photosensitizer | 0.13 0.046 CID_105131 | ||
| 0.153 | 0.061 | 0.153 | Neuropeptide Y1 antagonist | 0.151 0.064 CID_105131 | ||
| 0.104 | 0.014 | 0.104 | Beta 3 adrenoreceptor antagonist | 0.076 0.026 CID_105131 | ||
| 0.109 | 0.02 | 0.109 | D-Ala-D-Ala ligase inhibitor | 0.097 0.033 CID_105131 | ||
| 0.141 | 0.052 | 0.188 | Proteasome inhibitor | 0.188 0.029 CID_105131 | CID_105131 | |
| 0.119 | 0.032 | 0.119 | Lanosterol 14 alpha demethylase inhibitor | 0.099 0.057 CID_105131 | ||
| 0.128 | 0.041 | 0.128 | Carbonic anhydrase XV inhibitor | 0.1 0.067 CID_105131 | ||
| 0.113 | 0.027 | 0.113 | Glutamate release inhibitor | 0.097 0.047 CID_105131 | ||
| 0.1 | 0.014 | 0.1 | Phospholipase D inhibitor | 0.087 0.026 CID_105131 | ||
| 0.131 | 0.045 | 0.131 | Mucolytic | 0.115 0.059 CID_105131 | ||
| 0.137 | 0.052 | 0.137 | Monophenol monooxygenase inhibitor | 0.129 0.056 CID_105131 | ||
| 0.116 | 0.033 | 0.116 | Histamine N-methyltransferase inhibitor | 0.082 0.065 CID_105131 | ||
| 0.161 | 0.078 | 0.161 | Neurotensin receptor agonist | 0.143 0.119 CID_105131 | ||
| 0.097 | 0.015 | 0.097 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.083 0.031 CID_105131 | ||
| 0.116 | 0.034 | 0.116 | Glutamate (mGluR7) agonist | 0.098 0.063 CID_105131 | ||
| 0.099 | 0.018 | 0.099 | Vanilloid 4 agonist | 0.085 0.032 CID_105131 | ||
| 0.117 | 0.036 | 0.117 | Estrogen receptor beta antagonist | 0.116 0.037 CID_105131 | ||
| 0.128 | 0.048 | 0.187 | Falcipain 3 inhibitor | 0.187 0.022 CID_105131 | CID_105131 | |
| 0.1 | 0.021 | 0.1 | Glycine receptor agonist | 0.089 0.029 CID_105131 | ||
| 0.123 | 0.044 | 0.123 | Acetylcholine release stimulant | 0.104 0.078 CID_105131 | ||
| 0.101 | 0.023 | 0.101 | Estrogen-related receptor beta agonist | 0.091 0.038 CID_105131 | ||
| 0.096 | 0.018 | 0.096 | Purinergic P2X1 antagonist | 0.094 0.019 CID_105131 | ||
| 0.111 | 0.034 | 0.129 | Acetylcholine nicotinic antagonist | 0.129 0.027 CID_105131 | CID_105131 | |
| 0.082 | 0.005 | 0.082 | Membrane dipeptidase inhibitor | 0.072 0.007 CID_105131 | ||
| 0.125 | 0.05 | 0.125 | MAO A inhibitor | 0.121 0.052 CID_105131 | ||
| 0.1 | 0.027 | 0.1 | GABA aminotransferase inhibitor | 0.096 0.03 CID_105131 | ||
| 0.109 | 0.036 | 0.194 | Catalase inhibitor | 0.194 0.016 CID_105131 | CID_105131 | |
| 0.138 | 0.066 | 0.138 | MAO inhibitor | 0.121 0.074 CID_105131 | ||
| 0.228 | 0.156 | 0.228 | Vasodilator, coronary | 0.196 0.185 CID_105131 | ||
| 0.202 | 0.131 | 0.241 | Transcription factor STAT3 inhibitor | 0.241 0.091 CID_105131 | CID_105131 | |
| 0.079 | 0.008 | 0.079 | Adenylate cyclase 1 inhibitor | 0.058 0.019 CID_105131 | ||
| 0.122 | 0.051 | 0.122 | Estrogen antagonist | 0.117 0.06 CID_105131 | ||
| 0.101 | 0.031 | 0.112 | Na+ K+ transporting ATPase inhibitor | 0.112 0.022 CID_105131 | CID_105131 | |
| 0.22 | 0.151 | 0.315 | Transcription factor NF kappa B inhibitor | 0.315 0.087 CID_105131 | CID_105131 | |
| 0.132 | 0.064 | 0.132 | Cyclooxygenase 3 inhibitor | 0.102 0.1 CID_105131 | ||
| 0.097 | 0.029 | 0.097 | Estrogen receptor alpha antagonist | 0.09 0.035 CID_105131 | ||
| 0.079 | 0.012 | 0.105 | Alpha-mannosidase inhibitor | 0.105 0.006 CID_105131 | CID_105131 | |
| 0.077 | 0.009 | 0.077 | Fructose-1,6-bisphosphatase inhibitor | 0.064 0.015 CID_105131 | ||
| 0.077 | 0.01 | 0.086 | Adenosine deaminase inhibitor | 0.086 0.008 CID_105131 | CID_105131 | |
| 0.086 | 0.019 | 0.134 | Ornithine carbamoyltransferase inhibitor | 0.134 0.011 CID_105131 | CID_105131 | |
| 0.071 | 0.005 | 0.071 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.061 0.007 CID_105131 | ||
| 0.091 | 0.026 | 0.091 | Acetylcholine M5 receptor agonist | 0.068 0.046 CID_105131 | ||
| 0.099 | 0.034 | 0.099 | mTOR complex 2 inhibitor | 0.082 0.064 CID_105131 | ||
| 0.074 | 0.009 | 0.074 | Urate transporter 1 inhibitor | 0.064 0.013 CID_105131 | ||
| 0.09 | 0.026 | 0.09 | GABA B receptor agonist | 0.081 0.039 CID_105131 | ||
| 0.156 | 0.092 | 0.186 | ATPase inhibitor | 0.186 0.051 CID_105131 | CID_105131 | |
| 0.111 | 0.048 | 0.111 | Sphingomyelinase inhibitor | 0.084 0.081 CID_105131 | ||
| 0.245 | 0.182 | 0.372 | Antibacterial | 0.372 0.09 CID_105131 | CID_105131 | |
| 0.089 | 0.027 | 0.089 | MAP kinase kinase 7 inhibitor | 0.077 0.054 CID_105131 | ||
| 0.086 | 0.025 | 0.105 | Aromatase inhibitor | 0.105 0.021 CID_105131 | CID_105131 | |
| 0.069 | 0.009 | 0.069 | Dopamine D5 agonist | 0.049 0.018 CID_105131 | ||
| 0.121 | 0.064 | 0.153 | Cholesterol synthesis inhibitor | 0.153 0.043 CID_105131 | CID_105131 | |
| 0.072 | 0.015 | 0.072 | Dihydroorotate oxidase inhibitor | 0.067 0.02 CID_105131 | ||
| 0.072 | 0.015 | 0.11 | Oleamide hydrolase inhibitor | 0.11 0.008 CID_105131 | CID_105131 | |
| 0.065 | 0.008 | 0.065 | Dihydrofolate reductase inhibitor | 0.065 0.008 CID_105131 | ||
| 0.123 | 0.067 | 0.123 | Sphingosine 1-phosphate receptor 4 antagonist | 0.112 0.09 CID_105131 | ||
| 0.079 | 0.023 | 0.079 | Acetylcholine muscarinic agonist | 0.059 0.034 CID_105131 | ||
| 0.111 | 0.055 | 0.111 | MAO B inhibitor | 0.091 0.065 CID_105131 | ||
| 0.162 | 0.107 | 0.162 | I kappa B kinase epsilon inhibitor | |||
| 0.137 | 0.081 | 0.137 | Pregnane X receptor agonist | 0.126 0.11 CID_105131 | ||
| 0.068 | 0.013 | 0.093 | Mannosidase inhibitor | 0.093 0.006 CID_105131 | CID_105131 | |
| 0.061 | 0.006 | 0.061 | Lysine carboxypeptidase inhibitor | 0.047 0.008 CID_105131 | ||
| 0.081 | 0.026 | 0.081 | Beta adrenoreceptor antagonist | 0.072 0.036 CID_105131 | ||
| 0.058 | 0.003 | 0.058 | Lysophosphatidic acid receptor 1 agonist | 0.047 0.004 CID_105131 | ||
| 0.108 | 0.054 | 0.108 | Carbonic anhydrase III inhibitor | |||
| 0.06 | 0.007 | 0.06 | Kainate receptor agonist | 0.053 0.011 CID_105131 | ||
| 0.125 | 0.072 | 0.125 | Toll-Like receptor 2 antagonist | 0.123 0.075 CID_105131 | ||
| 0.061 | 0.008 | 0.061 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.049 0.012 CID_105131 | ||
| 0.087 | 0.034 | 0.087 | Sphingosine 1-phosphate receptor antagonist | 0.074 0.06 CID_105131 | ||
| 0.09 | 0.037 | 0.09 | CC chemokine 5 receptor agonist | 0.078 0.073 CID_105131 | ||
| 0.059 | 0.007 | 0.059 | Glutamate (mGluR8) agonist | 0.054 0.009 CID_105131 | ||
| 0.07 | 0.018 | 0.07 | Ryanodine receptor antagonist | 0.06 0.037 CID_105131 | ||
| 0.068 | 0.017 | 0.068 | Pregnane X receptor antagonist | 0.067 0.018 CID_105131 | ||
| 0.061 | 0.01 | 0.061 | Alpha 1d adrenoreceptor agonist | 0.047 0.018 CID_105131 | ||
| 0.143 | 0.092 | 0.173 | Melanin inhibitor | 0.173 0.057 CID_105131 | CID_105131 | |
| 0.079 | 0.029 | 0.079 | NMDA receptor glycine site agonist | 0.062 0.044 CID_105131 | ||
| 0.06 | 0.011 | 0.06 | Guanylate cyclase inhibitor | 0.048 0.023 CID_105131 | ||
| 0.108 | 0.06 | 0.108 | Expectorant | 0.093 0.076 CID_105131 | ||
| 0.057 | 0.01 | 0.057 | Histamine H1 receptor agonist | 0.048 0.021 CID_105131 | ||
| 0.064 | 0.018 | 0.064 | Estradiol 17 beta-dehydrogenase inhibitor | 0.054 0.022 CID_105131 | ||
| 0.06 | 0.014 | 0.06 | Histamine H2 receptor agonist | 0.048 0.024 CID_105131 | ||
| 0.156 | 0.111 | 0.156 | Psychostimulant | 0.153 0.113 CID_105131 | ||
| 0.063 | 0.018 | 0.063 | Immunoglobulin Fc receptor antagonist | 0.055 0.037 CID_105131 | ||
| 0.135 | 0.09 | 0.135 | Acetylcholine M1 receptor antagonist | |||
| 0.053 | 0.009 | 0.053 | Melatonin 1 agonist | |||
| 0.072 | 0.027 | 0.072 | Transcription factor RelA inhibitor | 0.063 0.046 CID_105131 | ||
| 0.064 | 0.019 | 0.064 | Lysophosphatidic acid 3 receptor antagonist | 0.053 0.031 CID_105131 | ||
| 0.129 | 0.087 | 0.129 | Cell wall synthesis inhibitor | 0.115 0.107 CID_105131 | ||
| 0.065 | 0.022 | 0.065 | Sphingosine 1-phosphate receptor 1 antagonist | 0.054 0.042 CID_105131 | ||
| 0.075 | 0.033 | 0.075 | Potassium channel (ATP-sensitive) blocker | |||
| 0.063 | 0.021 | 0.063 | Acetylcholine M1 receptor agonist | 0.041 0.032 CID_105131 | ||
| 0.089 | 0.047 | 0.089 | Carbonic anhydrase VI inhibitor | |||
| 0.057 | 0.016 | 0.057 | Benzodiazepine antagonist | 0.048 0.031 CID_105131 | ||
| 0.059 | 0.018 | 0.068 | Thymidylate synthase inhibitor | 0.068 0.013 CID_105131 | CID_105131 | |
| 0.06 | 0.02 | 0.06 | Potassium channel (Inward rectifier) activator | 0.048 0.04 CID_105131 | ||
| 0.056 | 0.015 | 0.056 | Thymidine kinase inhibitor | 0.046 0.022 CID_105131 | ||
| 0.065 | 0.025 | 0.065 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.058 0.032 CID_105131 | ||
| 0.085 | 0.045 | 0.089 | Nicotinic alpha4beta2 receptor antagonist | 0.089 0.041 CID_105131 | CID_105131 | |
| 0.072 | 0.033 | 0.072 | 5 Hydroxytryptamine 3 agonist | 0.059 0.051 CID_105131 | ||
| 0.048 | 0.009 | 0.062 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.062 0.007 CID_105131 | CID_105131 | |
| 0.072 | 0.033 | 0.072 | MDM2 inhibitor | |||
| 0.055 | 0.017 | 0.062 | Geranyltranstransferase inhibitor | 0.062 0.012 CID_105131 | CID_105131 | |
| 0.057 | 0.019 | 0.057 | Potassium channel (ATP-sensitive) activator | 0.046 0.039 CID_105131 | ||
| 0.084 | 0.046 | 0.09 | Interferon agonist | 0.09 0.039 CID_105131 | CID_105131 | |
| 0.19 | 0.153 | 0.216 | Transcription factor STAT inhibitor | 0.216 0.117 CID_105131 | CID_105131 | |
| 0.083 | 0.045 | 0.083 | Keratolytic | 0.069 0.067 CID_105131 | ||
| 0.05 | 0.013 | 0.05 | Heme oxygenase inhibitor | 0.043 0.028 CID_105131 | ||
| 0.091 | 0.054 | 0.091 | Acetylcholine agonist | 0.088 0.057 CID_105131 | ||
| 0.112 | 0.075 | 0.112 | Transcription factor STAT6 inhibitor | |||
| 0.058 | 0.022 | 0.058 | Squalene epoxidase inhibitor | 0.048 0.037 CID_105131 | ||
| 0.131 | 0.095 | 0.196 | Thiol protease inhibitor | 0.196 0.04 CID_105131 | CID_105131 | |
| 0.07 | 0.035 | 0.07 | Interferon inducer | |||
| 0.069 | 0.034 | 0.069 | Adenosine A1 receptor antagonist | 0.061 0.038 CID_105131 | ||
| 0.043 | 0.008 | 0.043 | Nicotinic alpha3beta4 receptor agonist | 0.033 0.017 CID_105131 | ||
| 0.075 | 0.04 | 0.075 | Sphingosine 1-phosphate receptor 4 agonist | 0.059 0.055 CID_105131 | ||
| 0.07 | 0.036 | 0.07 | NMDA receptor agonist | 0.056 0.054 CID_105131 | ||
| 0.041 | 0.006 | 0.041 | Purinergic P2Y15 antagonist | 0.036 0.01 CID_105131 | ||
| 0.184 | 0.151 | 0.184 | Neuropeptide Y2 antagonist | |||
| 0.12 | 0.088 | 0.12 | Vanilloid 1 agonist | |||
| 0.076 | 0.046 | 0.076 | Potassium channel (Tandem pore domain) blocker | 0.069 0.068 CID_105131 | ||
| 0.065 | 0.036 | 0.065 | Carbonic anhydrase stimulant | |||
| 0.058 | 0.029 | 0.058 | Nicotinic alpha3beta2 receptor antagonist | |||
| 0.053 | 0.024 | 0.056 | Carbonic anhydrase VII inhibitor | 0.056 0.022 CID_105131 | CID_105131 | |
| 0.056 | 0.028 | 0.067 | Antimetabolite | 0.067 0.023 CID_105131 | CID_105131 | |
| 0.049 | 0.022 | 0.049 | Glutamate (mGluR4) antagonist | 0.042 0.033 CID_105131 | ||
| 0.065 | 0.037 | 0.065 | Corticotropin releasing factor 2 receptor antagonist | |||
| 0.033 | 0.005 | 0.033 | Complement factor 1s inhibitor | 0.03 0.009 CID_105131 | ||
| 0.094 | 0.066 | 0.151 | Interleukin 1 beta converting enzyme inhibitor | 0.151 0.017 CID_105131 | CID_105131 | |
| 0.035 | 0.008 | 0.035 | Estrogen-related receptor gamma antagonist | 0.028 0.02 CID_105131 | ||
| 0.048 | 0.021 | 0.048 | Nerve growth factor antagonist | 0.043 0.029 CID_105131 | ||
| 0.036 | 0.01 | 0.036 | Nicotinic alpha4beta2 receptor agonist | 0.032 0.014 CID_105131 | ||
| 0.06 | 0.035 | 0.06 | Carbonic anhydrase VB inhibitor | |||
| 0.033 | 0.007 | 0.033 | Vanilloid 2 agonist | 0.028 0.013 CID_105131 | ||
| 0.045 | 0.019 | 0.045 | AMPA 4 receptor antagonist | 0.036 0.034 CID_105131 | ||
| 0.065 | 0.04 | 0.065 | Calcium channel P-type blocker | |||
| 0.033 | 0.008 | 0.033 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.029 0.013 CID_105131 | ||
| 0.04 | 0.016 | 0.04 | 1-Alkyl-2-acetylglycerophosphocholine esterase inhibitor | 0.033 0.026 CID_105131 | ||
| 0.037 | 0.013 | 0.037 | Uridine phosphorylase inhibitor | 0.025 0.022 CID_105131 | ||
| 0.028 | 0.005 | 0.028 | Carbonic anhydrase VIII inhibitor | 0.022 0.007 CID_105131 | ||
| 0.028 | 0.005 | 0.028 | Carbonic anhydrase X inhibitor | 0.022 0.007 CID_105131 | ||
| 0.033 | 0.009 | 0.033 | Nicotinic acid receptor 2 antagonist | 0.028 0.016 CID_105131 | ||
| 0.059 | 0.036 | 0.059 | Beta 1 adrenoreceptor antagonist | 0.054 0.041 CID_105131 | ||
| 0.048 | 0.025 | 0.048 | Oxytocin agonist | 0.039 0.033 CID_105131 | ||
| 0.032 | 0.011 | 0.032 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.027 0.013 CID_105131 | ||
| 0.042 | 0.02 | 0.042 | Potassium channel Kv1.1 blocker | 0.037 0.028 CID_105131 | ||
| 0.027 | 0.005 | 0.027 | Thymidine kinase (Herpes simplex virus 2) inhibitor | 0.022 0.011 CID_105131 | ||
| 0.025 | 0.004 | 0.025 | Telomerase stimulant | 0.021 0.006 CID_105131 | ||
| 0.084 | 0.063 | 0.104 | Ornithine decarboxylase inhibitor | 0.104 0.04 CID_105131 | CID_105131 | |
| 0.112 | 0.091 | 0.112 | DNA repair enzyme inhibitor | |||
| 0.043 | 0.022 | 0.053 | GABA uptake inhibitor | 0.053 0.013 CID_105131 | CID_105131 | |
| 0.057 | 0.036 | 0.057 | Sphingosine kinase 2 inhibitor | |||
| 0.036 | 0.015 | 0.036 | Glutamate (mGluR3) agonist | 0.032 0.022 CID_105131 | ||
| 0.026 | 0.006 | 0.026 | Ileal bile acid transport inhibitor | 0.016 0.013 CID_105131 | ||
| 0.05 | 0.029 | 0.05 | Cytokine production stimulant | |||
| 0.029 | 0.009 | 0.029 | Glutamate (mGluR1a) agonist | 0.029 0.009 CID_105131 | ||
| 0.031 | 0.011 | 0.031 | Hedgehog signaling activator | 0.026 0.023 CID_105131 | ||
| 0.04 | 0.021 | 0.04 | Vanilloid 3 antagonist | |||
| 0.046 | 0.027 | 0.046 | Glutamate (mGluR group III) antagonist | |||
| 0.085 | 0.067 | 0.085 | Pim-3 kinase inhibitor | |||
| 0.03 | 0.012 | 0.03 | Thymidine phosphorylase inhibitor | 0.025 0.019 CID_105131 | ||
| 0.055 | 0.037 | 0.066 | Ribonucleoside-diphosphate reductase inhibitor | 0.066 0.031 CID_105131 | CID_105131 | |
| 0.118 | 0.1 | 0.118 | Nav1.6 sodium channel blocker | |||
| 0.064 | 0.046 | 0.064 | Aryl hydrocarbon receptor antagonist | |||
| 0.045 | 0.028 | 0.045 | Carbonic anhydrase IV inhibitor | |||
| 0.039 | 0.022 | 0.039 | Glutamate (mGluR3) antagonist | |||
| 0.056 | 0.039 | 0.067 | Ribonucleotide reductase inhibitor | 0.067 0.033 CID_105131 | CID_105131 | |
| 0.067 | 0.05 | 0.067 | Carbonic anhydrase VA inhibitor | |||
| 0.079 | 0.063 | 0.079 | Glutathione S-transferase inhibitor | 0.077 0.066 CID_105131 | ||
| 0.033 | 0.018 | 0.033 | Epoxide hydrolase 1 inhibitor | |||
| 0.028 | 0.013 | 0.028 | Acid ceramidase inhibitor | |||
| 0.035 | 0.02 | 0.035 | Protein kinase (CK2) beta inhibitor | |||
| 0.025 | 0.01 | 0.025 | Isoleucine-tRNA ligase inhibitor | 0.022 0.018 CID_105131 | ||
| 0.04 | 0.026 | 0.04 | CF transmembrane conductance regulator antagonist | |||
| 0.038 | 0.024 | 0.038 | Arginase inhibitor | |||
| 0.021 | 0.007 | 0.024 | Methylmalonyl-CoA mutase inhibitor | 0.024 0.004 CID_105131 | CID_105131 | |
| 0.114 | 0.1 | 0.114 | Protein kinase stimulant | |||
| 0.03 | 0.017 | 0.03 | MAP3K8 inhibitor | |||
| 0.052 | 0.039 | 0.055 | Heparanase inhibitor | 0.055 0.033 CID_105131 | CID_105131 | |
| 0.069 | 0.055 | 0.069 | Epoxide hydrolase inhibitor | |||
| 0.078 | 0.066 | 0.078 | Inducible nitric-oxide synthase inhibitor | |||
| 0.087 | 0.075 | 0.087 | MAP kinase kinase 1 inhibitor | |||
| 0.063 | 0.051 | 0.078 | Neuronal nicotinic receptor antagonist | 0.078 0.038 CID_105131 | CID_105131 | |
| 0.049 | 0.037 | 0.049 | Beta 2 adrenoreceptor antagonist | 0.045 0.044 CID_105131 | ||
| 0.053 | 0.041 | 0.062 | Glucosylceramidase inhibitor | 0.062 0.029 CID_105131 | CID_105131 | |
| 0.048 | 0.036 | 0.048 | Potassium channel (Inward rectifier) blocker | |||
| 0.194 | 0.183 | 0.194 | Vasodilator, peripheral | |||
| 0.043 | 0.032 | 0.059 | AICAR transformylase inhibitor | 0.059 0.015 CID_105131 | CID_105131 | |
| 0.017 | 0.006 | 0.017 | Lysophosphatidic acid receptor 3 agonist | 0.013 0.01 CID_105131 | ||
| 0.035 | 0.024 | 0.035 | Phosphoglycerate kinase inhibitor | |||
| 0.057 | 0.047 | 0.057 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.031 | 0.02 | 0.031 | Lysophosphatidic acid 2 receptor antagonist | |||
| 0.016 | 0.005 | 0.016 | Carbonic anhydrase XI inhibitor | 0.013 0.009 CID_105131 | ||
| 0.102 | 0.092 | 0.102 | Interleukin 8 antagonist | |||
| 0.058 | 0.048 | 0.058 | Cannabinoid CB1 receptor antagonist | |||
| 0.022 | 0.012 | 0.022 | Retinoid X beta receptor antagonist | 0.02 0.016 CID_105131 | ||
| 0.018 | 0.008 | 0.018 | Purinergic P2Y1 agonist | 0.015 0.011 CID_105131 | ||
| 0.019 | 0.01 | 0.019 | Alpha 2a adrenoreceptor agonist | |||
| 0.015 | 0.006 | 0.015 | 1-Deoxy-D-xylulose-5-phosphate reductoisomerase inhibitor | 0.012 0.011 CID_105131 | ||
| 0.031 | 0.022 | 0.031 | Potassium channel small-conductance Ca-activated activator | |||
| 0.023 | 0.015 | 0.023 | Prostaglandin F2 alpha agonist | 0.021 0.019 CID_105131 | ||
| 0.038 | 0.03 | 0.038 | 5 Hydroxytryptamine 2B agonist | |||
| 0.026 | 0.018 | 0.026 | Sodium/glucose cotransporter 2 inhibitor | |||
| 0.018 | 0.009 | 0.018 | Vitamin D receptor agonist | |||
| 0.026 | 0.018 | 0.026 | Sodium/glucose cotransporter inhibitor | |||
| 0.038 | 0.03 | 0.038 | Dihydropteroate synthase inhibitor | |||
| 0.017 | 0.009 | 0.017 | Thromboxane A2 agonist | 0.016 0.01 CID_105131 | ||
| 0.014 | 0.007 | 0.014 | Glutamate (mGluR6) agonist | 0.011 0.01 CID_105131 | ||
| 0.045 | 0.038 | 0.045 | Aldosterone antagonist | |||
| 0.03 | 0.023 | 0.03 | Prostaglandin agonist | |||
| 0.034 | 0.027 | 0.034 | Ceramide glucosyltransferase inhibitor | |||
| 0.021 | 0.014 | 0.021 | Factor XIII inhibitor | |||
| 0.046 | 0.04 | 0.046 | Topoisomerase II beta inhibitor | |||
| 0.081 | 0.075 | 0.081 | Bromodomain-containing protein 2 inhibitor | |||
| 0.06 | 0.054 | 0.06 | Carbonic anhydrase V inhibitor | |||
| 0.044 | 0.038 | 0.044 | CC chemokine 4 receptor antagonist | |||
| 0.021 | 0.015 | 0.021 | Neuraminidase (Influenza B) inhibitor | |||
| 0.019 | 0.013 | 0.019 | Antibiotic Anthracycline-like | |||
| 0.03 | 0.024 | 0.03 | ATP citrate lysase inhibitor | |||
| 0.036 | 0.03 | 0.036 | Retinoid X receptor antagonist | |||
| 0.138 | 0.132 | 0.138 | MAP kinase kinase 2 inhibitor | |||
| 0.017 | 0.011 | 0.019 | Nicotinic alpha4 receptor agonist | 0.019 0.008 CID_105131 | CID_105131 | |
| 0.051 | 0.046 | 0.051 | Epithelial sodium channel blocker | |||
| 0.091 | 0.086 | 0.108 | Beta glucuronidase inhibitor | 0.108 0.058 CID_105131 | CID_105131 | |
| 0.032 | 0.027 | 0.032 | Retinoid X alpha receptor antagonist | |||
| 0.017 | 0.012 | 0.017 | Nicotinic acid receptor 1 antagonist | |||
| 0.02 | 0.015 | 0.02 | Imidazoline I1 receptor antagonist | |||
| 0.023 | 0.018 | 0.023 | Fructose-1,6-bisphosphatase 1 inhibitor | |||
| 0.009 | 0.004 | 0.009 | DNA topoisomerase III inhibitor | 0.007 0.005 CID_105131 | ||
| 0.059 | 0.054 | 0.059 | Histone deacetylase SIRT3 inhibitor | |||
| 0.033 | 0.029 | 0.033 | Adenosine uptake inhibitor | |||
| 0.024 | 0.019 | 0.024 | Glutamate (mGluR1) agonist | 0.023 0.022 CID_105131 | ||
| 0.094 | 0.09 | 0.094 | Adenylate cyclase inhibitor | |||
| 0.018 | 0.014 | 0.018 | Alpha 2b adrenoreceptor agonist | 0.018 0.016 CID_105131 | ||
| 0.013 | 0.009 | 0.013 | Cyclin D2 inhibitor | |||
| 0.017 | 0.014 | 0.017 | Cyclin T1 inhibitor | |||
| 0.018 | 0.015 | 0.018 | 5-Alpha-reductase 2 inhibitor | |||
| 0.027 | 0.024 | 0.027 | 5 Hydroxytryptamine 6 agonist | |||
| 0.013 | 0.01 | 0.013 | Melatonin receptor 1A antagonist | |||
| 0.026 | 0.023 | 0.026 | Glucosylceramidase stimulant | |||
| 0.055 | 0.052 | 0.07 | Cyclin D1 inhibitor | 0.07 0.029 CID_105131 | CID_105131 | |
| 0.059 | 0.056 | 0.059 | Beta 2 adrenoreceptor agonist | |||
| 0.073 | 0.071 | 0.073 | Calcium antagonist | |||
| 0.021 | 0.019 | 0.021 | Prostaglandin E2 agonist | |||
| 0.022 | 0.02 | 0.022 | Protein 30S ribosomal subunit inhibitor | |||
| 0.042 | 0.041 | 0.042 | Purinergic P2X4 antagonist | |||
| 0.063 | 0.065 | 0.096 | Carbonic anhydrase XIII inhibitor | 0.096 0.04 CID_105131 | CID_105131 | |
| 0.039 | 0.044 | 0.181 | Kallikrein inhibitor | 0.181 0.005 CID_105131 | CID_105131 | |
| 0.042 | 0.051 | 0.049 | HCV NS3/NS4A protease inhibitor | 0.049 0.033 CID_105131 | CID_105131 | |
| 0.03 | 0.04 | 0.052 | Cathepsin L1 inhibitor | 0.052 0.019 CID_105131 | CID_105131 | |
| 0.066 | 0.08 | 0.251 | Chymotrypsin inhibitor | 0.251 0.005 CID_105131 | CID_105131 | |
| 0.041 | 0.056 | 0.048 | Prolyl endopeptidase inhibitor | 0.048 0.039 CID_105131 | CID_105131 | |
| 0.044 | 0.06 | 0.069 | Cathepsin L inhibitor | 0.069 0.031 CID_105131 | CID_105131 | |
| 0.032 | 0.049 | 0.061 | Phosphorylase inhibitor | 0.061 0.024 CID_105131 | CID_105131 | |
| 0.056 | 0.077 | 0.088 | Cathepsin G inhibitor | 0.088 0.038 CID_105131 | CID_105131 | |
| 0.031 | 0.053 | 0.04 | Leukocyte elastase inhibitor | 0.04 0.033 CID_105131 | CID_105131 | |
| 0.014 | 0.041 | 0.018 | Caspase 8 inhibitor | 0.018 0.017 CID_105131 | CID_105131 | |
| 0.004 | 0.033 | 0.009 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.009 0.004 CID_105131 | CID_105131 | |
| 0.124 | 0.162 | 0.185 | Non-steroidal antiinflammatory agent | 0.185 0.083 CID_105131 | CID_105131 | |
| 0.132 | 0.172 | 0.192 | Immunostimulant | 0.192 0.125 CID_105131 | CID_105131 | |
| 0.029 | 0.082 | 0.055 | Xanthine dehydrogenase inhibitor | 0.055 0.042 CID_105131 | CID_105131 | |
| 0.162 | 0.232 | 0.239 | Antithrombotic | 0.239 0.135 CID_105131 | CID_105131 | |
| 0.081 | 0.152 | 0.13 | NADPH oxidase inhibitor | 0.13 0.071 CID_105131 | CID_105131 | |
| 0.16 | 0.232 | 0.345 | Calpain 2 inhibitor | 0.345 0.089 CID_105131 | CID_105131 | |
| 0.197 | 0.278 | 0.557 | Apoptosis agonist | 0.557 0.059 CID_105131 | CID_105131 | |
| 0.017 | 0.201 | 0.08 | Antineoplastic antibiotic | 0.08 0.057 CID_105131 | CID_105131 | |
| 0.004 | 0.278 | 0.715 | Calpain 1 inhibitor | 0.715 0.001 CID_105131 | CID_105131 | |
| 0.018 | 0.363 | 0.13 | Topoisomerase II alpha inhibitor | 0.13 0.027 CID_105131 | CID_105131 | |
| 0.046 | 0.48 | 0.168 | Hepatoprotectant | 0.168 0.091 CID_105131 | CID_105131 | |
| 0.041 | 0.554 | 0.298 | Immunosuppressant | 0.298 0.116 CID_105131 | CID_105131 | |
| 0.016 | 0.643 | 0.21 | Thioredoxin glutathione reductase inhibitor | 0.21 0.164 CID_105131 | CID_105131 | |
| 0.018 | 0.674 | 0.12 | Interleukin 1 antagonist | 0.12 0.089 CID_105131 | CID_105131 | |
| 0.016 | 0.678 | 0.196 | Nitric oxide antagonist | 0.196 0.069 CID_105131 | CID_105131 | |
| 0.005 | 0.913 | 0.107 | Trypsin inhibitor | 0.107 0.014 CID_105131 | CID_105131 | |
| 0.003 | 0.914 | 0.121 | Cathepsin K inhibitor | 0.121 0.004 CID_105131 | CID_105131 | |
| 0.015 | 0.986 | 0.497 | Factor V inhibitor | 0.497 0.001 CID_105131 | CID_105131 | |
| 0.005 | 0.98 | 0.096 | Elastase 1 inhibitor | 0.096 0.022 CID_105131 | CID_105131 | |
| 0.004 | 0.988 | 0.131 | Protease inhibitor | 0.131 0.04 CID_105131 | CID_105131 | |
| 0 | 0.987 | 0.011 | Immunosuppressant Cyclosporine-like | 0.011 0.009 CID_105131 | CID_105131 | |
| 0.001 | 0.987 | 0.063 | 3C-Like protease (MERS coronavirus) inhibitor | 0.063 0.002 CID_105131 | CID_105131 | |
| 0.003 | 0.996 | 0.202 | Anticoagulant | 0.202 0.052 CID_105131 | CID_105131 | |
| 0.004 | 0.997 | 0.419 | 3C-Like protease (SARS coronavirus) inhibitor | 0.419 0.002 CID_105131 | CID_105131 | |
| 0.002 | 0.996 | 0.112 | Factor XII inhibitor | 0.112 0.028 CID_105131 | CID_105131 | |
| 0.001 | 0.995 | 0.035 | Caspase 2 inhibitor | 0.035 0.019 CID_105131 | CID_105131 | |
| 0.002 | 0.997 | 0.139 | Protein 50S ribosomal subunit inhibitor | 0.139 0.007 CID_105131 | CID_105131 | |
| 0.002 | 0.997 | 0.097 | Thrombin inhibitor | 0.097 0.027 CID_105131 | CID_105131 | |
| 0.001 | 0.997 | 0.031 | Caspase 6 inhibitor | 0.031 0.019 CID_105131 | CID_105131 | |
| 0.001 | 0.997 | 0.079 | Plasminogen activator inhibitor | 0.079 0.026 CID_105131 | CID_105131 | |
| 0.002 | 0.998 | 0.105 | ABCA1 expression enhancer | 0.105 0.044 CID_105131 | CID_105131 | |
| 0.001 | 0.998 | 0.344 | Cathepsin B inhibitor | 0.344 0.004 CID_105131 | CID_105131 | |
| 0.001 | 0.998 | 0.15 | Plasmin inhibitor | 0.15 0.01 CID_105131 | CID_105131 | |
| 0.001 | 0.998 | 0.216 | Apoptosis antagonist | 0.216 0.16 CID_105131 | CID_105131 | |
| 0.001 | 0.999 | 0.157 | Caspase 9 inhibitor | 0.157 0.005 CID_105131 | CID_105131 | |
| 0 | 0.999 | 0.015 | Antibiotic Macrolide-like | 0.015 0.009 CID_105131 | CID_105131 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |